|
HSD17B11 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.08900000004042E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.00529999999844E-06 |
| Normal-vs-Stage2 |
2.691800E-02 |
| Normal-vs-Stage3 |
1.648350E-02 |
| Normal-vs-Stage4 |
5.562900E-03 |
| Stage1-vs-Stage2 |
8.207200E-01 |
| Stage1-vs-Stage3 |
2.876000E-01 |
| Stage1-vs-Stage4 |
8.105000E-01 |
| Stage2-vs-Stage3 |
6.547600E-01 |
| Stage2-vs-Stage4 |
9.744400E-01 |
| Stage3-vs-Stage4 |
5.764600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.38929999996085E-06 |
| Normal-vs-AfricanAmerican |
9.196400E-02 |
| Normal-vs-Asian |
2.513400E-01 |
| Caucasian-vs-AfricanAmerican |
6.157800E-02 |
| Caucasian-vs-Asian |
6.914800E-01 |
| AfricanAmerican-vs-Asian |
8.115400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.29579999999618E-05 |
| Normal-vs-Female |
1.045580E-04 |
| Male-vs-Female |
9.817000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.951800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.794180E-04 |
| Normal-vs-Age(61-80Yrs) |
1.78928999999828E-05 |
| Normal-vs-Age(81-100Yrs) |
2.143500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.202400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.368970E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.136300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.658600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.550600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.253000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.770000E-04 |
| Normal-vs-Grade 2 |
4.04859999969531E-07 |
| Normal-vs-Grade 3 |
6.33469999999914E-05 |
| Normal-vs-Grade 4 |
9.004800E-01 |
| Grade 1-vs-Grade 2 |
3.400200E-01 |
| Grade 1-vs-Grade 3 |
8.842000E-02 |
| Grade 1-vs-Grade 4 |
1.962270E-04 |
| Grade 2-vs-Grade 3 |
2.548200E-01 |
| Grade 2-vs-Grade 4 |
1.57155999999103E-05 |
| Grade 3-vs-Grade 4 |
4.557600E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.78201897682584E-12 |
| Normal-vs-ccB subtype |
5.308200E-01 |
| ccA subtype-vs-ccB subtype |
1.46309631077202E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.28770000000522E-05 |
| Normal-vs-N1 |
3.437400E-01 |
| N0-vs-N1 |
4.855600E-01 |
|
|
